- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Perinatal Management for a Pregnant Woman with an<i>MYH9</i>Disorder
-
- Yuka Yamashita
- Department of Obstetrics and Gynecology, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Japan
-
- Rei Matsuura
- Department of Obstetrics and Gynecology, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Japan
-
- Shinji Kunishima
- Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
-
- Yoshie Oikawa
- Department of Clinical Laboratory, Showa University Fujigaoka Hospital, Yokohama, Japan
-
- Hirotsugu Ariizumi
- Department of Hematology, Showa University Fujigaoka Hospital, Yokohama, Japan
-
- Shoko Hamada
- Department of Obstetrics and Gynecology, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Japan
-
- Nahoko Shirato
- Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan
-
- Ryu Matsuoka
- Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan
-
- Kohichi Ogawa
- Department of Obstetrics and Gynecology, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama 227-8501, Japan
-
- Akihiko Sekizawa
- Department of Obstetrics and Gynecology, Showa University School of Medicine, Tokyo, Japan
Search this article
Description
<jats:p>We diagnosed a primipara woman with an<jats:italic>MYH9</jats:italic>disorder during her pregnancy. A peripheral blood smear with an immunofluorescence analysis is the established method of diagnosing<jats:italic>MYH9</jats:italic>disorders. We provided genetic counseling, as required, which included apprising the woman of the inheritance pattern, the importance of a genetic analysis, and the potential delivery risks for the patient and her offspring. Given that the potential delivery risks are reportedly low, special perinatal management is not necessary for patients with an<jats:italic>MYH9</jats:italic>disorder whose platelet count is above 5.0 × 10<jats:sup>4</jats:sup>/<jats:italic>μ</jats:italic>L, except for rapid blood access.</jats:p>
Journal
-
- Case Reports in Obstetrics and Gynecology
-
Case Reports in Obstetrics and Gynecology 2016 1-3, 2016
Wiley